Phase 1 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a body mass index (BMI) between 18.0 and 32.0 (a measure of body weight relative to height), inclusive — this applies to certain parts of the trial only
- People taking part in Parts C and D of the trial must weigh at least 50 kilograms and have a BMI between 18.0 and 40.0, inclusive
- People taking part in Parts C and D must have been diagnosed with rheumatoid arthritis (a condition where the immune system attacks the joints) as an adult, for at least 3 months before joining the trial
Who may not be able to join:
- Healthy participants in Parts A and B: People who have had, or currently have, serious conditions affecting the heart, lungs, liver, eyes, kidneys, digestive system, hormones, blood, nervous system, or mental health, where those conditions could affect how the body processes medicines
- People with rheumatoid arthritis in Parts C and D: Those whose rheumatoid arthritis has been classified as "Class 4" — the most severe category — according to established medical guidelines
- People with rheumatoid arthritis in Parts C and D: Those who show an abnormal result on a heart electrical activity test (called an ECG) at the screening stage
- People with rheumatoid arthritis in Parts C and D: Those who currently have, or have recently had, an active infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.